Treating acute ischemic stroke in a patient with multiple sclerosis: A challenging issue.
Sign Up to like & getrecommendations! Published in 2020 at "Multiple sclerosis and related disorders"
DOI: 10.1016/j.msard.2020.101962
Abstract: Multiple sclerosis (MS) is a chronic disease characterized by inflammation, demyelination and neurodegeneration in the central nervous system. Recent studies suggested that patients with MS might have a greater risk of ischaemic stroke (IS). IS… read more here.
Keywords: sclerosis; ischemic stroke; treating acute; multiple sclerosis ... See more keywords
Identification of Pyrrolo[2,3- d]pyrimidine-Based Derivatives as Potent and Orally Effective Fms-like Tyrosine Receptor Kinase 3 (FLT3) Inhibitors for Treating Acute Myelogenous Leukemia.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of medicinal chemistry"
DOI: 10.1021/acs.jmedchem.9b00223
Abstract: A series of pyrrolo[2,3- d]pyrimidine derivatives were prepared and optimized for cytotoxic activities against FLT3-ITD mutant cancer cells. Among them, compound 9u possessed nanomolar FLT3 inhibitory activities and subnanomolar inhibitory activities against MV4-11 and Molm-13… read more here.
Keywords: treating acute; pyrrolo pyrimidine; kinase; myelogenous leukemia ... See more keywords
Things We Do for No Reason™: Discontinuing Buprenorphine When Treating Acute Pain.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of hospital medicine"
DOI: 10.12788/jhm.3265
Abstract: Medications to treat OUD include methadone, buprenorphine, and extended-release naltrexone. Buprenorphine is a Schedule III medication under the United States Food and Drug Administration that reduces opioid cravings, subsequently decreasing drug use1 and opioid-related overdose… read more here.
Keywords: treating acute; things reason; buprenorphine treating; buprenorphine ... See more keywords